Abstract 3581: Multi-omic analysis identifies mechanisms of resistance to CD19 CAR T-cell therapy in children with acute lymphoblastic leukemia
Katherine E. Masih(National Institutes of Health), Javed Khan(National Institutes of Health), Rimas J. Orentas(Capital Caring), Michael C. Kelly(National Cancer Institute), Serifat Adebola(National Cancer Institute), Grégoire Altan‐Bonnet(National Cancer Institute), Jun S. Wei(National Cancer Institute), Abdalla Abdelmaksoud(National Cancer Institute), Ashley Wilson(The University of Texas MD Anderson Cancer Center), Benjamin Z. Stanton(Nationwide Children's Hospital), Martha L. Bulyk(Broad Institute), Vineela Gangalapudi(National Cancer Institute), Hsien-Chao Chou(National Cancer Institute), Young Song(University of British Columbia), Rebecca Gardner(Seattle Children's Hospital), Berkley E. Gryder(University School), Chaoyu Wang(Chongqing University), Xinyu Wen(National Institutes of Health), Luca Mariani(Brigham and Women's Hospital), Michael C. Jensen(Seattle Children's Hospital)
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
The multiple mechanisms that regulate p53 activity and cell fate
|Nature Reviews Molecular Cell Biology|2019|1.1k